Literature DB >> 8346669

The sequence of hepatitis E virus isolated directly from a single source during an outbreak in China.

S L Bi1, M A Purdy, K A McCaustland, H S Margolis, D W Bradley.   

Abstract

In this study an IgM antibody-mediated antigen-capture procedure for direct extraction of hepatitis E virus (HEV) RNA from clinical specimens was developed and used with an efficient method for generating viral cDNA that was subsequently sequenced using the dideoxy chain termination method. This is the first time the complete HEV genome has been isolated directly from a single human clinical specimen obtained during an outbreak of enterically transmitted non-A, non-B hepatitis. When the Chinese-derived sequence was compared with the original isolate of Burmese HEV from an experimentally infected cynomolgus macaque, the homology between the two sequences was 94% and 98.5% at the nucleotide and amino acid levels, respectively. The methods we developed for generating and sequencing genomic HEV cDNA dramatically improved the efficiency of cloning the viral genome and should be helpful for continued analysis of this virus as well as other RNA viruses that have proven to be difficult to clone and sequence directly.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8346669     DOI: 10.1016/0168-1702(93)90024-h

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  26 in total

1.  Evidence of recombination between divergent hepatitis E viruses.

Authors:  Hélène van Cuyck; Jun Fan; David L Robertson; Pierre Roques
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

2.  Expression and self-assembly of empty virus-like particles of hepatitis E virus.

Authors:  T C Li; Y Yamakawa; K Suzuki; M Tatsumi; M A Razak; T Uchida; N Takeda; T Miyamura
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

3.  Identification by phage display and characterization of two neutralizing chimpanzee monoclonal antibodies to the hepatitis E virus capsid protein.

Authors:  D J Schofield; J Glamann; S U Emerson; R H Purcell
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

4.  Experimental infection of Z:ZCLA Mongolian gerbils with human hepatitis E virus.

Authors:  Yan Hong; Zhuo-Jing He; Wei Tao; Ting Fu; Yan-Kun Wang; Yong Chen
Journal:  World J Gastroenterol       Date:  2015-01-21       Impact factor: 5.742

5.  The ORF3 protein of hepatitis E virus is a phosphoprotein that associates with the cytoskeleton.

Authors:  M Zafrullah; M H Ozdener; S K Panda; S Jameel
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

6.  Detection of sporadic cases of hepatitis E virus (HEV) infection in China using immunoassays based on recombinant open reading frame 2 and 3 polypeptides from HEV genotype 4.

Authors:  Y Wang; H Zhang; Z Li; W Gu; H Lan; W Hao; R Ling; H Li; T J Harrison
Journal:  J Clin Microbiol       Date:  2001-12       Impact factor: 5.948

7.  A new Chinese isolate of hepatitis E virus: comparison with strains recovered from different geographical regions.

Authors:  S Yin; R H Purcell; S U Emerson
Journal:  Virus Genes       Date:  1994-09       Impact factor: 2.332

8.  Characterization of a strain of infectious hepatitis E virus isolated from sewage in an area where hepatitis E is not endemic.

Authors:  S Pina; J Jofre; S U Emerson; R H Purcell; R Girones
Journal:  Appl Environ Microbiol       Date:  1998-11       Impact factor: 4.792

9.  Polyphyletic strains of hepatitis E virus are responsible for sporadic cases of acute hepatitis in Japan.

Authors:  Hitoshi Mizuo; Kazuyuki Suzuki; Yasuhiro Takikawa; Yoshiki Sugai; Hajime Tokita; Yoshihiro Akahane; Keiichi Itoh; Yuhko Gotanda; Masaharu Takahashi; Tsutomu Nishizawa; Hiroaki Okamoto
Journal:  J Clin Microbiol       Date:  2002-09       Impact factor: 5.948

10.  Expression in animal cells and characterization of the hepatitis E virus structural proteins.

Authors:  S Jameel; M Zafrullah; M H Ozdener; S K Panda
Journal:  J Virol       Date:  1996-01       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.